Correlation Between Synmosa Biopharma and CTCI Corp

Can any of the company-specific risk be diversified away by investing in both Synmosa Biopharma and CTCI Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Synmosa Biopharma and CTCI Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Synmosa Biopharma and CTCI Corp, you can compare the effects of market volatilities on Synmosa Biopharma and CTCI Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Synmosa Biopharma with a short position of CTCI Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Synmosa Biopharma and CTCI Corp.

Diversification Opportunities for Synmosa Biopharma and CTCI Corp

0.87

Correlation Coefficient

Synmosa Biopharma  CTCI Corp

Very poor diversification

The 3 months correlation between Synmosa and CTCI is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Synmosa Biopharma and CTCI Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CTCI Corp and Synmosa Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Synmosa Biopharma are associated (or correlated) with CTCI Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CTCI Corp has no effect on the direction of Synmosa Biopharma i.e., Synmosa Biopharma and CTCI Corp go up and down completely randomly.

Pair Corralation between Synmosa Biopharma and CTCI Corp

Assuming the 90 days trading horizon Synmosa Biopharma is expected to generate 0.84 times more return on investment than CTCI Corp. However, Synmosa Biopharma is 1.18 times less risky than CTCI Corp. It trades about -0.19 of its potential returns per unit of risk. CTCI Corp is currently generating about -0.32 per unit of risk. If you would invest  3,740  in Synmosa Biopharma on September 4, 2024 and sell it today you would lose (330.00) from holding Synmosa Biopharma or give up 8.82% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Synmosa Biopharma  vs.  CTCI Corp

Synmosa Biopharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Synmosa Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

CTCI Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days CTCI Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Synmosa Biopharma and CTCI Corp

The main advantage of trading using opposite Synmosa Biopharma and CTCI Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Synmosa Biopharma position performs unexpectedly, CTCI Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CTCI Corp will offset losses from the drop in CTCI Corp's long position.

The idea behind Synmosa Biopharma and CTCI Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.